| 1. | About eu yan sang group ses : eysi
关于余仁生国际有限公司新加坡交易所： eysi |
| 2. | The share of a mainland chinese company listed on the singapore stock exchange
在新加坡交易所上市的中国大陆公司。 |
| 3. | At the end of july 2002 , dmx lodged an application to the singapore stock exchange for a public listing on its main board
二零零二年七月底，宏天科技已向新加坡交易所申请在主板上市。 |
| 4. | Listed on the singapore stock exchange , eu yan sang international limited is a progressive , global healthcare company with its core focus in traditional chinese medicine
余仁生国际有限公司在新加坡交易所上市，是一家以传统中药为核心进取的环球保健公司。 |
| 5. | Listed on the singapore exchange , eu yan sang international limited eu yan sang is a progressive , global healthcare company with a core focus on traditional chinese medicine
余仁生国际有限公司于新加坡交易所上市，为一家与时并进以传统中药为本的环球保健产品集团。 |
| 6. | Listed on the singapore exchange , eu yan sang international limited eu yan sang is a progressive , global healthcare company with its core focus in traditional chinese medicine
余仁生国际有限公司于新加坡交易所上市，为一家与时并进以传统中药为本的环球保健产品集团。 |
| 7. | Mark lee p . l . is vice president and head of securities marketing and business development at singapore exchange ( sgx ) , where he is responsible for promoting and developing its securities business
李彬凌，新加坡交易所副总裁兼证券交易署事业发展部主任，负责发展证券业务。 |
| 8. | Prior to the merger of the stock exchange of singapore ( ses ) and singapore international monetary exchange ( simex ) on 1 dec 1999 , mark worked with simex ( equity andinterest rate derivatives marketing )
在新加坡交易所与新加坡金融期货交易所合并前，任职新加坡金融期货交易所。 |
| 9. | Eu yan sang hong kong limited is a wholly - owned subsidiary of eu yan sang international limited , which has been listed on the mainboard of the singapore exchange since july 2000
余仁生香港有限公司为余仁生国际有限公司之全资附属公司，后者自二零零零年七月起在新加坡交易所主板上市。 |
| 10. | About eu yan sang group listed on the singapore exchange , eu yan sang international limited is a progressive , global healthcare company with its core focus in traditional chinese medicine
余仁生国际有限公司在新加坡交易所上市，为一家进取专注于中药的环球保健公司，集团宗旨为向客户提供最优质天然保健产品。 |
